GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, will present at the Canaccord Genuity Medical Technology and Diagnostics Forum to be held at the Westin Grand Central Hotel in New York, NY on Thursday, November 20, 2014. The presentation will be delivered by Scott Mendel, Chief Financial Officer and is scheduled to begin at 9:30 a.m. Eastern Time (6:30 a.m. Pacific Time). The presentation will be made available at http://ir.genmarkdx.com/.
Help employers find you! Check out all the jobs and post your resume.
